Streetbeat News

Price Targets

CPA

In the past three months, 4 analysts have rated Copa Holdings (NYSE:CPA) with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has increased to $160.75. Analysts have adjusted their ratings and price targets based on recent market conditions and company performance.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 2:01 pm

ALLO

In the last three months, 6 analysts have published ratings on Allogene Therapeutics (NASDAQ:ALLO), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has decreased by 27.89% to $11.43. Analysts have adjusted their ratings and price targets in response to changing market dynamics and company performance.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 2:01 pm

CVS

In the last three months, 5 analysts have published ratings on CVS Health (NYSE:CVS), with a mix of somewhat bullish and indifferent sentiments. The average 12-month price target has decreased by 7.8% to $65.0. Key analysts have adjusted their ratings and price targets, reflecting dynamic market conditions and company performance.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 2:01 pm

TNGX

Tango Therapeutics (NASDAQ:TNGX) has been analyzed by 7 analysts, showing a range of bullish to somewhat bullish sentiments. The average 12-month price target is $13.71, down 10.57% from the previous $15.33. Recent analyst actions include both raises and lowers in price targets, reflecting dynamic market conditions. Tango Therapeutics is a biotechnology company focused on precision oncology therapies.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 2:00 pm

WLK

Analysts have provided mixed ratings for Westlake (NYSE:WLK) over the past three months, with a recent increase in the average 12-month price target to $163.6. Key analysts have adjusted their ratings and price targets, reflecting diverse outlooks on the company's performance.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 2:00 pm

NI

In the last three months, 6 analysts have published ratings on NiSource (NYSE:NI), with all ratings being somewhat bullish. The average 12-month price target has increased by 4.84% to $32.5. Analysts have raised their price targets and maintained positive ratings, indicating a favorable outlook despite recent revenue declines.

Portfolio Pulse from Benzinga Insights

August 08, 2024 | 2:00 pm

BROS

Wedbush analyst Nick Setyan has reiterated an Outperform rating on Dutch Bros (NYSE:BROS) and maintained a $45 price target.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:59 pm

CHWY

Wedbush analyst Seth Basham has reiterated an Outperform rating on Chewy (NYSE:CHWY) and maintained a $35 price target.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:57 pm

CTRA

UBS analyst Josh Silverstein maintains a Buy rating on Coterra Energy (NYSE:CTRA) but lowers the price target from $36 to $34.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:55 pm

TCPC

Keefe, Bruyette & Woods analyst Paul Johnson maintains a Market Perform rating on BlackRock TCP Capital (NASDAQ:TCPC) but lowers the price target from $10.5 to $9.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 1:54 pm